PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
PACS Group, Inc.NYSE: PACS
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) grows, but more slowly than its trailing trend
Q2 FY2026 EPS (Diluted) of $0.47 rose 51.6% year over year, behind the +103.7% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 6.0% from the prior quarter. Over 3 fiscal years it compounded at +6.9% a year.
Context
- EPS (Diluted) increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 3 analysts of $2.44 (+99.9%) for the fiscal year ending Dec 2026, a slowdown from the +221.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $0.47-6.0% QoQ
- Last fiscal yearDec 2025
- $1.22+221.1% YoY
- LTMJun 2026
- $1.67+103.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +51.6% | +81.0% | +29.3 pp |
| 1 year | +221.1% | +99.9% | -121.2 pp |
| 3-year CAGR | +6.9% | +36.2% | +29.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 1.22 USD
- Year-over-year change
- +221.1%
- 4-year CAGR
- +39.7%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.22 | +221.1% |
| FY2024 | 2024-12-31 | 0.38 | -49.3% |
| FY2023 | 2023-12-31 | 0.75 | -25.0% |
| FY2022 | 2022-12-31 | 1.00 | +212.5% |
| FY2021 | 2021-12-31 | 0.32 | — |
EPS (Diluted) vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's LTM Jun 2026 EPS (Diluted) of $1.67 is the 6th highest of the 11 companies compared; the peer median is $3.5.
- Its year-over-year change of +103.7% is the 2nd highest of 11, against a peer median of +18.0%.
- Over three fiscal years its annual growth of +6.9% compares with a peer median of +41.7%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $29.87 | +25.5% | +14.0% | |
| LTM Mar 2026 | $12.88 | +8.4% | — | |
| LTM Sep 2026 | $7.24 | +11.7% | +74.2% | |
| LTM Jun 2026 | $6.38 | +15.8% | +13.9% | |
| LTM Jun 2026 | $6.14 | +20.2% | +27.1% | |
| LTM Jun 2026 | $1.67 | +103.7% | +6.9% | |
| LTM Mar 2026 | $0.85 | +11.8% | +56.3% | |
| LTM Jun 2026 | $0.13 | +366.3% | — | |
| LTM Sep 2026 | -$0.16 | +87.9% | — | |
| LTM Mar 2026 | -$0.3 | -27.6% | — | |
| LTM Mar 2026 | -$0.65 | +82.3% | +120.8% | |
| Peer median (excluding PACS) | $3.5 | +18.0% | +41.7% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 2.42B | 3.11B | 4.09B | 5.29B |
| Cost of Revenue | 979.22M | 2.02B | 2.66B | 3.3B | 4.13B |
| Gross Profit | 187.35M | 400.68M | 447.07M | 792.64M | 1.16B |
| Gross Margin | 16.1% | 16.5% | 14.4% | 19.4% | 21.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 96.83M | 149.01M | 213.66M | 343.81M | 415.07M |
| Operating Expenses | 103.99M | 171.32M | 239.3M | 669.57M | 849.64M |
| Depreciation & Amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| EBITDA | 93.86M | 254.89M | 232.87M | 186.7M | 365.57M |
| EBITDA Margin | 8.0% | 10.5% | 7.5% | 4.6% | 6.9% |
| Operating Income | 83.36M | 229.36M | 207.77M | 123.07M | 309.6M |
| Operating Margin | 7.1% | 9.5% | 6.7% | 3.0% | 5.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.28M | 25.54M | 49.92M | 44.34M | 28.36M |
| Other Income / Expenses | (1.93M) | (22.32M) | (50.46M) | (21.52M) | (25.15M) |
| Income Before Tax | 81.43M | 207.05M | 157.32M | 101.55M | 284.45M |
| Pre-Tax Margin | 7.0% | 8.5% | 5.1% | 2.5% | 5.4% |
| Income Tax Expense | 33.48M | 56.55M | 44.44M | 46.21M | 92.99M |
| Net Income | 47.95M | 150.5M | 112.87M | 55.76M | 191.54M |
| Net Margin | 4.1% | 6.2% | 3.6% | 1.4% | 3.6% |
| EPS (Basic) | 0.32 | 1.00 | 0.75 | 0.38 | 1.23 |
| EPS (Diluted) | 0.32 | 1.00 | 0.75 | 0.38 | 1.22 |
| Weighted Avg Shares | 150.15M | 150.15M | 150.15M | 146.66M | 156.18M |
| Weighted Avg Shares (Diluted) | 150.15M | 150.15M | 150.15M | 148.57M | 156.7M |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.